KORU Medical Systems Inc. (KRMD)
(Delayed Data from NSDQ)
$2.60 USD
-0.13 (-4.76%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $2.60 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$2.60 USD
-0.13 (-4.76%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $2.60 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Zacks News
Repro Med Systems, Inc. (KRMD) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Repro Med Systems, Inc. (KRMD) delivered earnings and revenue surprises of 33.33% and 5.89%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Veracyte (VCYT) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Veracyte (VCYT) delivered earnings and revenue surprises of -7.14% and 6.07%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Silk Road Medical (SILK) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Silk Road Medical (SILK) delivered earnings and revenue surprises of -5% and 8.75%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Repro Med Systems, Inc. (KRMD) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Repro Med Systems, Inc. (KRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Repro Med Systems, Inc. (KRMD) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Repro Med Systems, Inc. (KRMD) delivered earnings and revenue surprises of 33.33% and 10.44%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Repro Med Systems, Inc. (KRMD) Q3 Earnings Expected to Decline
by Zacks Equity Research
Repro Med Systems, Inc. (KRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Repro Med Systems, Inc. (KRMD) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Repro Med Systems, Inc. (KRMD) delivered earnings and revenue surprises of 33.33% and 10.34%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Repro Med Systems, Inc. (KRMD) Q2 Earnings Expected to Decline
by Zacks Equity Research
Repro Med Systems, Inc. (KRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Repro Med Systems, Inc. (KRMD) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Repro Med Systems, Inc. (KRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Repro Med Systems (KRMD) in Focus: Stock Moves 6.8% Higher
by Zacks Equity Research
Repro Med Systems (KRMD) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Repro Med Systems (KRMD) Surges: Stock Moves 8.8% Higher
by Zacks Equity Research
Repro Med Systems (KRMD) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
Yes, You Can Time the Market. Find out How - August 27, 2020
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Timing the Market, Is it Possible? - August 07, 2020
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
How to Time the Markets Like an Investing Pro - July 20, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?